Liu Y
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Immunology top 0.5%
- Immune Response and Inflammation
Papers in
-
- Cancer-related molecular mechanisms research 18
- Cancer, Hypoxia, and Metabolism 16
- Immunology 54
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 16
- Co-authors
- Nikki J. HolbrookMyriam GorospeLeif D. NelinKathryn Z. GuytonQingbo XuEdward G. ShepherdJennifer L. MartindaleXiantao Wang
- Journals
- Journal of Biological Chemistry (19 papers)The Journal of Immunology (18 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (7 papers)Molecular and Cellular Biology (6 papers)The FASEB Journal (5 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Liu Y
283 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Cancer Research 1.9k
- Immunology 2.5k
- Molecular Biology 7.4k
- Toxicology 291
- Aging 118
Countries citing papers authored by Liu Y
This map shows the geographic impact of Liu Y's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu Y with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu Y more than expected).
Fields of papers citing papers by Liu Y
This network shows the impact of papers produced by Liu Y. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu Y. The network helps show where Liu Y may publish in the future.
Co-authors
The 25 scholars most cited alongside Liu Y, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | Tanshinone IIA Promotes Axonal Regeneration in Rats with Focal Cerebral Ischemia Through the Inhibition of Nogo-A/NgR1/RhoA/ROCKII/MLC Signaling | 2020 | 2 |
| 3 | AZIN1-AS1, A Novel Oncogenic LncRNA, Promotes the Progression of Non-Small Cell Lung Cancer by Regulating MiR-513b-5p and DUSP11 | 2020 | 3 |
| 4 | Cysteine Potentiates Bactericidal Antibiotics Activity Against Gram-Negative Bacterial Persisters | 2020 | 1 |
| 5 | MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 | 2020 | 1 |
| 6 | Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications | 2020 | 2 |
| 7 | The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study | 2020 | 1 |
| 8 | The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells | 2020 | 0 |
| 9 | A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer | 2020 | 2 |
| 10 | Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a | 2020 | 2 |
| 11 | Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer | 2019 | 1 |
| 12 | Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro | 2019 | 2 |
| 13 | MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer | 2019 | 2 |
| 14 | Photoluminescent And Self-Assembled Hyaluronic Acid-Zinc Oxide-Ginsenoside Rh2 Nanoparticles And Their Potential Caspase-9 Apoptotic Mechanism Towards Cancer Cell Lines | 2019 | 1 |
| 15 | Therapies targeting the signal pathways of pheochromocytoma and paraganglioma | 2019 | 2 |
| 16 | Ozone oxidative postconditioning inhibits oxidative stress and apoptosis in renal ischemia and reperfusion injury through inhibition of MAPK signaling pathway | 2018 | 3 |
| 17 | Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1 | 2018 | 1 |
| 18 | 2018 | 18 | |
| 19 | Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma | 2016 | 3 |
| 20 | 2010 | 30 |
About Liu Y
Liu Y is a scholar working on Cancer Research, Immunology, Molecular Biology, Toxicology and Oncology, having authored 299 papers that have together received 12.3k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (28 papers), Cancer-related molecular mechanisms research (18 papers), Cytokine Signaling Pathways and Interactions (18 papers), Melanoma and MAPK Pathways (17 papers), Cancer, Hypoxia, and Metabolism (16 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (16 papers), Circular RNAs in diseases (14 papers) and Nitric Oxide and Endothelin Effects (14 papers). The work is most often cited by research in Cancer Research (1.9k citations), Immunology (2.5k citations), Molecular Biology (7.4k citations), Toxicology (291 citations) and Aging (118 citations). Liu Y has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Nikki J. Holbrook, Myriam Gorospe, Leif D. Nelin, Kathryn Z. Guyton, Qingbo Xu, Edward G. Shepherd, Jennifer L. Martindale, Xiantao Wang, Xianxi Wang and Dorothy Hutter. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Molecular and Cellular Biology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.